• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

FDA staff raises no new concerns about Abbott's heart device

cafead

Administrator
Staff member
  • cafead   Feb 11, 2024 at 03:52: PM
via The U.S. Food and Drug Administration (FDA) staff reviewers did not raise any new concerns on Friday over the safety and effectiveness of Abbott's (ABT.N), opens new tab heart valve repair device designed for patients who are at risk for surgery.

article source